268 related articles for article (PubMed ID: 15498816)
21. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
[TBL] [Abstract][Full Text] [Related]
22. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1).
Voehringer D; Koschella M; Pircher H
Blood; 2002 Nov; 100(10):3698-702. PubMed ID: 12393723
[TBL] [Abstract][Full Text] [Related]
23. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity.
Ito M; Maruyama T; Saito N; Koganei S; Yamamoto K; Matsumoto N
J Exp Med; 2006 Feb; 203(2):289-95. PubMed ID: 16461340
[TBL] [Abstract][Full Text] [Related]
24. Non-peptide antigens activating human Vgamma9/Vdelta2 T lymphocytes.
Poupot M; Fournié JJ
Immunol Lett; 2004 Sep; 95(2):129-38. PubMed ID: 15388252
[TBL] [Abstract][Full Text] [Related]
25. Porcine T lymphocytes and NK cells--an update.
Gerner W; Käser T; Saalmüller A
Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
[TBL] [Abstract][Full Text] [Related]
26. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells.
Lafarge X; Pitard V; Ravet S; Roumanes D; Halary F; Dromer C; Vivier E; Paul P; Moreau JF; Déchanet-Merville J
Eur J Immunol; 2005 Jun; 35(6):1896-905. PubMed ID: 15864777
[TBL] [Abstract][Full Text] [Related]
27. The human Vδ2
Davey MS; Willcox CR; Hunter S; Kasatskaya SA; Remmerswaal EBM; Salim M; Mohammed F; Bemelman FJ; Chudakov DM; Oo YH; Willcox BE
Nat Commun; 2018 May; 9(1):1760. PubMed ID: 29720665
[TBL] [Abstract][Full Text] [Related]
28. Primary MHC-class II(+) cells are necessary to promote resting Vδ2 cell expansion in response to (E)-4-hydroxy-3-methyl-but-2-enyl-pyrophosphate and isopentenyl pyrophosphate.
Soriano-Sarabia N; Sandvold H; Jomaa H; Kubin T; Bein G; Hackstein H
J Immunol; 2012 Dec; 189(11):5212-22. PubMed ID: 23105138
[TBL] [Abstract][Full Text] [Related]
29. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
[TBL] [Abstract][Full Text] [Related]
30. Activation of V gamma 9V delta 2 T cells by NKG2D.
Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells.
Petrini I; Pacini S; Petrini M; Fazzi R; Trombi L; Galimberti S
Eur J Clin Invest; 2009 Sep; 39(9):813-8. PubMed ID: 19522834
[TBL] [Abstract][Full Text] [Related]
32. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
33. Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity.
Rischer M; Pscherer S; Duwe S; Vormoor J; Jürgens H; Rossig C
Br J Haematol; 2004 Aug; 126(4):583-92. PubMed ID: 15287953
[TBL] [Abstract][Full Text] [Related]
34. Acquisition of a stimulatory activity for Vgamma9/Vdelta2 T cells by a Burkitt's lymphoma cell line without loss of HLA class I expression.
L'Faqihi FE; Guiraud M; Dastugue N; Brousset P; Le Bouteiller P; Halary F; Bonneville M; Fournié JJ; Champagne E
Hum Immunol; 1999 Oct; 60(10):928-38. PubMed ID: 10566592
[TBL] [Abstract][Full Text] [Related]
35. Cellular interactions of synovial fluid γδ T cells in juvenile idiopathic arthritis.
Bendersky A; Marcu-Malina V; Berkun Y; Gerstein M; Nagar M; Goldstein I; Padeh S; Bank I
J Immunol; 2012 May; 188(9):4349-59. PubMed ID: 22450805
[TBL] [Abstract][Full Text] [Related]
36. Thiopyrophosphoantigens: solid-phase synthesis and in vitro characterization of a new class of Vgamma9 Vdelta2 T cells activators.
Breccia P; Angeli F; Cerbara I; Topai A; Auricchio G; Martino A; Colizzi V; Poccia F
J Med Chem; 2009 Jun; 52(12):3716-22. PubMed ID: 19453173
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
Pietschmann K; Beetz S; Welte S; Martens I; Gruen J; Oberg HH; Wesch D; Kabelitz D
Scand J Immunol; 2009 Sep; 70(3):245-55. PubMed ID: 19703014
[TBL] [Abstract][Full Text] [Related]
38. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
Guo BL; Liu Z; Aldrich WA; Lopez RD
Breast Cancer Res Treat; 2005 Sep; 93(2):169-75. PubMed ID: 16187237
[TBL] [Abstract][Full Text] [Related]
39. Distinct cytokine-driven responses of activated blood gammadelta T cells: insights into unconventional T cell pleiotropy.
Vermijlen D; Ellis P; Langford C; Klein A; Engel R; Willimann K; Jomaa H; Hayday AC; Eberl M
J Immunol; 2007 Apr; 178(7):4304-14. PubMed ID: 17371987
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a subset of antigen-specific human central memory CD4+ T lymphocytes producing effector cytokines.
Stubbe M; Vanderheyde N; Pircher H; Goldman M; Marchant A
Eur J Immunol; 2008 Jan; 38(1):273-82. PubMed ID: 18081039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
